Base Pair Biotechnologies, Inc.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Jan 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 19, 2026The maintenance fee for Functional ligands to target molecules (US 9,035,034) comes due Nov 19, 2026. Unpaid by May 19, 2027, it lapses early.
- 1 fee due Feb 15, 2027The maintenance fee for Functional ligands to opioids and opioid derivatives (US 11,725,240) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
- 1 fee due Jul 21, 2027The maintenance fee for Functional ligands to chikungunya envelope proteins (US 10,538,770) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
- 1 fee due Oct 30, 2027The maintenance fee for Methods and materials for multiplexed collections of functional ligands (US 11,970,785) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,927,381 | Functional ligands to LL37 In force · From the USPTO record | In force | From the USPTO record | |
| US 9,035,034 | Functional ligands to target molecules In force · From the USPTO record | In force | From the USPTO record | |
| US 11,725,240 | Functional ligands to opioids and opioid derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 8,314,052 | Methods for simultaneous generation of functional ligands In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 11,078,489 | Methods and Compositions for Backscattering Interferometry In force · High confidence | In force | High confidence | |
| US 10,538,770 | Functional ligands to chikungunya envelope proteins In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 10,941,444 | Functional ligands to lipoarabinomannan In force · From the USPTO record | In force | From the USPTO record | |
| US 11,427,825 | Functional Ligands to Drug Compounds In force · High confidence | In force | High confidence | |
| US 10,676,781 | Functional ligands to THC In force · From the USPTO record | In force | From the USPTO record | |
| US 11,970,785 | Methods and materials for multiplexed collections of functional ligands In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 13: 1 patent in force now held by others · 4 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 abandoned · 14 no status recorded